France coronavirus death toll above 24,000, number of cases tweaked

The number of people in French hospitals with the COVID-19 infection fell to 26,834 from 27,484 on Tuesday, recording a 2.4% decline, its sharpest since a downward trend began 15 days ago.

Reuters

April 30, 2020 / 11:20 AM IST

Representative Image

The number of people who have died from the coronavirus infection in France rose by 427 to 24,087 on Wednesday, with the rate of increase slightly speeding up again after slowing on Tuesday, the health ministry said in a statement.

According to the ministry, the number of confirmed cases now stands at 128,442, up 1,607 over 24 hours. The figure stood at 129,859 on Tuesday but was tweaked a day after Prime Minister Edouard Philippe said that France would not end its coronavirus lockdown unless the number of new cases falls below 3,000 per day.

"It's a statistical readjustment linked to a change in the sampling", a ministry spokesman said.

The death toll has increased by 1.8% over 24 hours, versus 1.6% on Tuesday and 1.9% on Monday. Out of the 24,087 total, 15,053 fatalities occurred in hospitals, a figure up 1.6%, and 9,034 in nursing homes, up 2%.

As Britain added nursing homes deaths to the tally from hospitals to give a total of 26,097 fatalities, it became the third-most affected country in the world behind the United States and Italy and ahead of Spain and France.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show